Literature DB >> 27423989

Epidemiology of Peripheral Arterial Disease and Critical Limb Ischemia.

Anahita Dua1, Cheong J Lee2.   

Abstract

With a rise in the aging popluation, the prevalence of peripheral arterial disease (PAD) is markedly increasing. The overall disease prevalence of PAD is in the range of 3%-10%, which increases to 15%-20% in persons older than 70 years of age. Given this upward trend in disease prevalence, the economic and societal burden of PAD would be considerable. The subgroup of patients who develop critical limb ischemia (CLI) represents the most challenging population to manage medically, surgically, and endovascularly. Patients with symptomatic PAD and CLI have an increased risk for death and cardiovascular events, especially in those with CLI who carry with them a substantial risk of limb loss. Advances in medical, surgical, and endovascular techniques have shown excellent outcomes in the treatment of these patients, however the optimal management paradigm has not been elucidated. This article reviews the classification and epidemiology, risk factors, natural history, and health care costs associated with PAD and CLI. Published by Elsevier Inc.

Entities:  

Keywords:  Amputations; Critical Limb Ischemia; Peripheral Arterial Disease; atherosclerosis; claudication

Mesh:

Year:  2016        PMID: 27423989     DOI: 10.1053/j.tvir.2016.04.001

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN: 1557-9808


  45 in total

Review 1.  HIV Infection and Risk of Cardiovascular Diseases Beyond Coronary Artery Disease.

Authors:  Revery P Barnes; John Charles A Lacson; Hossein Bahrami
Journal:  Curr Atheroscler Rep       Date:  2017-05       Impact factor: 5.113

2.  Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model.

Authors:  Bian Wu; Evan C Werlin; Mian Chen; Giorgio Mottola; Anuran Chatterjee; Kevin D Lance; Daniel A Bernards; Brian E Sansbury; Matthew Spite; Tejal A Desai; Michael S Conte
Journal:  J Vasc Surg       Date:  2018-07-29       Impact factor: 4.268

Review 3.  Peripheral arterial disease: Scoping review of patient-centred outcomes.

Authors:  Laura Bolton
Journal:  Int Wound J       Date:  2019-10-09       Impact factor: 3.315

4.  Efficient generation of endothelial cells from induced pluripotent stem cells derived from a patient with peripheral arterial disease.

Authors:  Bootsakorn Boonkaew; Siriwal Suwanpitak; Kovit Pattanapanyasat; Nuttawut Sermsathanasawadi; Methichit Wattanapanitch
Journal:  Cell Tissue Res       Date:  2022-01-24       Impact factor: 5.249

Review 5.  Preventing Major Amputations in Patients with Critical Limb Ischemia.

Authors:  Eric W Rudofker; Shea E Hogan; Ehrin J Armstrong
Journal:  Curr Cardiol Rep       Date:  2018-07-10       Impact factor: 2.931

6.  Acute kidney injury following endovascular intervention for peripheral artery disease.

Authors:  E Katsogridakis; T Lea; T Yap; A Batchelder; P Saha; A Diamantopoulos; N Saratzis; R Davies; H Zayed; M J Bown; A Saratzis
Journal:  Br J Surg       Date:  2021-03-12       Impact factor: 6.939

Review 7.  Prostanoids for critical limb ischaemia.

Authors:  Valeria Vietto; Juan Va Franco; Victoria Saenz; Denise Cytryn; Jose Chas; Agustín Ciapponi
Journal:  Cochrane Database Syst Rev       Date:  2018-01-10

8.  Precision Medicine Enables More TNM-Like Staging in Patients With Chronic Limb Threatening Ischemia.

Authors:  Katharine L McGinigle; Nikki L B Freeman; William A Marston; Alik Farber; Michael S Conte; Michael R Kosorok; Corey A Kalbaugh
Journal:  Front Cardiovasc Med       Date:  2021-07-16

9.  Deciphering the in vivo Dynamic Proteomics of Mesenchymal Stem Cells in Critical Limb Ischemia.

Authors:  Yipeng Du; Xiaoting Li; Wenying Yan; Zhaohua Zeng; Dunzheng Han; Hong Ouyang; Xiudi Pan; Bihui Luo; Bohua Zhou; Qiang Fu; Dongfeng Lu; Zheng Huang; Zhiliang Li
Journal:  Front Cell Dev Biol       Date:  2021-06-30

10.  National Trends for Peripheral Artery Disease and End Stage Renal Disease From the National Inpatient Sample Database.

Authors:  Frank De Stefano; Luis H Paz Rios; Brian Fiani; Jawed Fareed; Alfonso Tafur
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.